Evidence map›Paper›PMID 33100362›Full record

ArticleThe Canadian journal of hospital pharmacy2020

Cannabinoid Hyperemesis Syndrome: A Case Report and Discussion Regarding Patients with Concurrent Disorders.

Stephen Lee-Cheong, Amrita Grewal, Lukas Hestvik, Reza Rafizadeh, Christian Schütz

Abstract readCase Reports
In one paragraph

Article in The Canadian journal of hospital pharmacy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Stephen Lee-Cheong, MB, BCh, BAO, is a student in the Post-Graduate Certificate in Pain Management program of the Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta.
Amrita Grewal, BSc, PharmD, was, at the time of this study, a student in the PharmD program of the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia. She has since graduated from the program.
Lukas Hestvik, MN-NP(F), BSN, is with the Burnaby Centre for Mental Health and Addiction, Burnaby, British Columbia.
Reza Rafizadeh, BSPharm, ACPR, BCPP, RPh, is with The University of British Columbia and the BC Psychosis Program, Vancouver, British Columbia, and is also with the Burnaby Centre for Mental Health and Addiction, Burnaby, British Columbia.
Christian Schütz, MD, PhD, MPH, FRCPC, is with the University of British Columbia, Vancouver, British Columbia, and the Burnaby Centre for Mental Health and Addiction, Burnaby, British Columbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33100362
PMCPMC7556397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.